checkAd
    Startseite > Aktien > Daxor > Nachrichten
    Daxor Aktie
    9,8000
     
    USD
    +0,93 %
    +0,0900 USD
    Letzter Kurs 15:30:01 Nasdaq
    9,0300
     
    USD
    100 STK
    Geldkurs 15:35:14
    9,9000
     
    USD
    1.500 STK
    Briefkurs 15:35:14
    ISIN: US2394671034 · WKN: 871275 · SYM: DXR · USA

    Neueste Nachrichten

    New Studies Prove the Clinical Benefits of Daxor’s Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of Congestion
    16.04.24 · globenewswire · Daxor
    DAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE SPRING’24 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100)
    15.04.24 · globenewswire · Daxor
    Daxor Corporation Announces New Hospital Account at Leading Chicago Hospital
    10.04.24 · globenewswire · Daxor
    Daxor Corporation to Exhibit at the American College of Cardiology for ACC.24
    01.04.24 · globenewswire · Daxor
    Daxor Corporation Acquires Volumex and Megatope From Its Existing Supplier Along With Glofil to Enhance Existing Suite of Diagnostics
    25.03.24 · globenewswire · Daxor
    Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024
    22.03.24 · globenewswire · Daxor
    Daxor Corporation Reports Increase in NAV to $7.08 Per Share and 31.8 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023
    18.03.24 · globenewswire · Daxor
    Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
    18.03.24 · globenewswire · Daxor
    Daxor Announces Sales to Three New Hospitals Furthering Expansion of Its User Base
    11.03.24 · globenewswire · Daxor
    Multi-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxor’s Unique Clinical Utility for Heart Failure Patients
    08.03.24 · globenewswire · Daxor
    Daxor Corporation to Exhibit at the Technology and Heart Failure Therapeutics Conference
    26.02.24 · globenewswire · Daxor
    Daxor Corporation Starts 2024 with Ongoing Growth in New Blood Volume Analyzer Acquisitions
    12.02.24 · globenewswire · Daxor